Purchase Order 75N98026P01168

<p>The National Institute of Neurological Disorders and Stroke awarded a purchase order to Olink Proteomics Inc. valued at $206,861.31 on May 29, 2026, for genome sequencing of DNA samples from patients with Lewy body dementia, amyotrophic lateral sclerosis, atypical parkinsonism, and frontotemporal dementia. The work is performed in Waltham, Massachusetts under firm fixed price terms. Ultimate completion is scheduled for May 28, 2027. No small business set-aside applies to this order.</p>

The U.S. Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke awarded a $198,740.56 firm fixed price purchase order to Olink Proteomics Inc., a foreign-owned for-profit biotechnology company, for Olink Explore 3072 reagent kits. The contract is for the delivery of these reagents by September 6, 2023. Olink Proteomics has a history of providing various proteomics instruments, reagents, kits, analysis services,...

Olink Proteomics Inc. was awarded a firm fixed-price purchase order valued at ninety-nine thousand three dollars and fifty-five cents ($99,003.55) by the National Institutes of Health Clinical Center (NIH CC) to provide an Olink Signature Q100 instrument for research use by the Critical Care Medicine Department (CCMD). The contract has a period of performance from June 23, 2023 through July 22, 2023 and will be performed in Waltham, Massachusetts. No subcontractors or set-aside designations were...

<p>The National Institutes of Health (Office of Logistics and Acquisition Operations) awarded a purchase order to Olink Proteomics Inc. for $47,300.00 on July 30, 2026, for Olink Explore HT service (product code 91959). Work is performed in Bethesda, Maryland. The order is firm fixed price with an ultimate completion date of July 29, 2027. No small business set-aside was used.</p>

<p>The National Institute on Aging awarded a purchase order to Olink Proteomics AB for $21,344.00 on September 15, 2017. Performance is located in Baltimore, Maryland. The order, which carries a firm fixed price, has an ultimate completion date of October 15, 2017. No set-aside category was used.</p>

<p>The NIH Clinical Center awarded a purchase order to Olink Proteomics Inc. for Olink reagents valued at $24,607.29, effective July 1, 2026, with completion by September 30, 2026. Performance occurs in Waltham, Massachusetts. The order is firm fixed price with no small business set-aside.</p>

<p>The National Institute of Neurological Disorders and Stroke awarded a purchase order to 10X Genomics, Inc. for $18,421.00 on December 10, 2019, with ultimate completion on December 10, 2020.</p> <p>Work is performed at the awardee's facility in Pleasanton, California. The order is firm fixed price with no set-aside. The source does not specify the particular genomic instruments, reagents, or consumables procured under this order.</p>

<p>The National Institute of Neurological Disorders and Stroke awarded a purchase order to Ocean Optics Inc. for $14,163.30 on December 18, 2019, under firm fixed price terms. Performance occurs in Largo, Florida. The order calls for spectroscopy equipment and related analytical instrumentation. Ultimate completion is scheduled for December 17, 2020.</p>

This federal contract award, valued at $10,558.00, was issued by the National Institutes of Health (NIH) Clinical Center to Olink Proteomics Inc., a foreign-owned, for-profit biotechnology company based in Waltham, Massachusetts. The contract is for a service agreement to provide the Olink Signature Q100 System, which is an advanced proteomics instrument used for protein biomarker discovery and analysis. The contract has a period of performance from August 5, 2025 to August 4, 2026 and is a firm...

The Department of Health and Human Services National Institutes of Health National Institute on Aging awarded a $203,298.48 firm fixed-price purchase order to Olink Proteomics Inc., a foreign-owned for-profit biotechnology company, to provide OLINK EXPLORE HT REAGENT KITS. The contract has a completion date of April 24, 2024 and does not have a set-aside designation. The original pre-solicitation notice indicates that the National Institutes of Health National Institute on Drug Abuse is...